JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$1.09B |
| 2 |
Broadcom
AVGO
|
+$1.03B |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$970M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$877M |
| 5 |
Verizon
VZ
|
+$875M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.37B |
| 3 |
TWX
Time Warner Inc
TWX
|
+$764M |
| 4 |
IBM
IBM
|
+$737M |
| 5 |
Philip Morris
PM
|
+$640M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Financials | 14% |
| 3 | Technology | 12.71% |
| 4 | Healthcare | 9.7% |
| 5 | Consumer Discretionary | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2551
PUT
United Parcel Service
UPS
$79.4B
| $5.18M | ﹤0.01% |
48,800
+4,300
| +10% | +$483K |
2016 Q4
6 quarters
|
|
|
CTLP
2552
DELISTED
Cantaloupe
CTLP
| $5.18M | ﹤0.01% |
369,713
+33,445
| +10% | +$380K |
2017 Q4
2 quarters
|
|
2553
PUT
Skyworks Solutions
SWKS
$12.7B
| $5.13M | ﹤0.01% |
53,100
| – | – |
2017 Q1
5 quarters
|
|
2554
CALL
HCA Healthcare
HCA
$92.1B
| $5.13M | ﹤0.01% |
50,000
| – | – |
2017 Q2
4 quarters
|
|
|
2555
PUT
HCA Healthcare
HCA
$92.1B
| $5.13M | ﹤0.01% |
50,000
| – | – |
2017 Q2
4 quarters
|
|
2556
Fate Therapeutics
FATE
$274M
| $5.12M | ﹤0.01% |
451,241
+23,821
| +6% | +$262K |
2017 Q1
5 quarters
|
|
2557
AstraZeneca
AZN
$243B
| $5.11M | ﹤0.01% |
72,766
-18,869
| -21% | -$1.36M |
2013 Q2
20 quarters
|
|
|
CBL
2558
DELISTED
CBL& Associates Properties, Inc.
CBL
| $5.1M | ﹤0.01% |
916,484
+232,920
| +34% | +$1.12M |
2013 Q2
20 quarters
|
|
|
LM
2559
DELISTED
Legg Mason, Inc.
LM
| $5.1M | ﹤0.01% |
146,729
-10,123
| -6% | -$384K |
2013 Q2
20 quarters
|
|
|
FL
2560
DELISTED
Foot Locker
FL
| $5.09M | ﹤0.01% |
96,777
-103,108
| -52% | -$4.99M |
2013 Q2
20 quarters
|
|
2561
United Fire Group
UFCS
$1.4B
| $5.08M | ﹤0.01% |
93,175
+8,549
| +10% | +$444K |
2013 Q2
20 quarters
|
|
2562
Ezcorp Inc
EZPW
$1.88B
| $5.07M | ﹤0.01% |
420,873
-809,553
| -66% | -$10.6M |
2016 Q2
8 quarters
|
|
2563
Innoviva
INVA
$1.49B
| $5.06M | ﹤0.01% |
366,948
+215,746
| +143% | +$3.23M |
2016 Q4
6 quarters
|
|
|
JOYY
2564
JOYY Inc
JOYY
$3.87B
| $5.05M | ﹤0.01% |
50,280
-617,327
| -92% | -$64.4M |
2015 Q4
10 quarters
|
|
|
SIR
2565
DELISTED
SELECT INCOME REIT
SIR
| $5.05M | ﹤0.01% |
511,115
+478,712
| +1,477% | +$4.31M |
2016 Q4
6 quarters
|
|
2566
Usana Health Sciences
USNA
$270M
| $5.04M | ﹤0.01% |
43,757
+1,481
| +4% | +$162K |
2013 Q2
20 quarters
|
|
2567
Fox Factory Holding Corp
FOXF
$784M
| $5.04M | ﹤0.01% |
108,245
+42,559
| +65% | +$1.64M |
2017 Q2
4 quarters
|
|
2568
Uranium Energy
UEC
$4.62B
| $5.03M | ﹤0.01% |
3,121,263
+20,271
| +0.7% | +$32.2K |
2016 Q1
9 quarters
|
|
|
BNY
2569
PUT
Bank of New York Mellon
BNY
$98.3B
| $5.02M | ﹤0.01% |
93,100
| – | – |
2017 Q3
3 quarters
|
|
2570
CALL
Williams Companies
WMB
$85.2B
| $5.01M | ﹤0.01% |
185,000
| – | – |
2018 Q1
1 quarter
|
|
|
OCLR
2571
DELISTED
Oclaro Inc.
OCLR
| $5.01M | ﹤0.01% |
561,137
-716,396
| -56% | -$6.27M |
2016 Q3
7 quarters
|
|
2572
Colliers International
CIGI
$4.66B
| $5M | ﹤0.01% |
66,043
-1,635
| -2% | -$118K |
2017 Q1
5 quarters
|
|
2573
PUT
Northrop Grumman
NOC
$68B
| $4.99M | ﹤0.01% |
+16,200
| New | +$5.36M |
2018 Q2
0 quarters
|
|
2574
Rhythm Pharmaceuticals
RYTM
$6.46B
| $4.97M | ﹤0.01% |
159,074
+1,621
| +1% | +$44.3K |
2017 Q4
2 quarters
|
|
2575
Covenant Logistics
CVLG
$859M
| $4.97M | ﹤0.01% |
315,282
-88,888
| -22% | -$1.36M |
2016 Q4
6 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2018 Portfolio in Review
As of Q2 2018, JP Morgan Chase held 5,918 positions worth $486B, up 4.2% from $467B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2018 filing shows 539 new, 2,430 increased, 2,080 reduced and 346 closed positions. Its largest new stake was Evergy: 3,598,208 shares worth $202M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.58B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2018 buy was Evergy: 3,598,208 shares worth $202M.
- JP Morgan Chase added most to Salesforce in Q2 2018, an estimated $1.09B increase.
- JP Morgan Chase's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.58B.
- JP Morgan Chase fully exited Time Warner Inc in Q2 2018, selling an estimated $764M.
- JP Morgan Chase's ten largest holdings make up 17% of its $486B portfolio in Q2 2018.
- JP Morgan Chase opened 539 new positions and closed 346 in Q2 2018.
- JP Morgan Chase's portfolio value rose 4.2% quarter-over-quarter to $486B.
Based on JP Morgan Chase's 13F filing for Q2 2018, filed 14 Aug 2018.